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have benefitted greatly from these interactions.   Results of our 
collaboration can be seen in the ROSIS project and associated short 
courses, involvement in clinical audit as members of the 
multidisciplinary team and several joint publications.  It is a great 
honour to receive this award and I am delighted to ‘finally’ be a 
physicist albeit it an honorary one – but maybe that is even better! 
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Purpose/Objective: Radiotherapy of several major tumour sites 
involves simultaneous treatment of multiple targets, typically 
occurring when irradiation of both the primary and elective targets is 
indicated. In the treatment of locally advanced prostate cancer, the 
dominating residual geometrical uncertainties following image-
guidance can be ascribed to deformations and uncorrelated motion of 
the involved targets: the prostate (CTV-p), the seminal vesicles (CTV-
sv) and the pelvic lymph nodes (CTV-ln). The aim of this study was to 
use a statistical deformation motion model to simulate target motion 
throughout a course of treatment in this clinical scenario, for the 
purpose of margin evaluations. 
Materials and Methods: The study was based on target delineations 
for 19 patients, all with a CT-set consisting of one planning and 9-10 
repeat CTs. After rigidly aligning the repeat CTs to the planning CT 
based on intra-prostatic markers, the displacement vectors between 
the target shapes in the planning CT and those in the repeat CTs were 
calculated with deformable registration. For each patient, a motion 
model based on principal component analysis (PCA) of these 
displacement vectors was created. From this model statistical 
meaningful inter- and extrapolations of the delineated target shapes 
were made to construct new target shapes according to their 
probabilities of occurrence and without prior assumptions of the 
relative importance of the different motion and deformation patterns. 
Maximally conformal synthetic dose distributions were created for 
various uniform CTV-to-PTV expansions in the planning CT. For each 
patient, the motion model was employed to analyse target coverage 
distributions for 1000 simulated treatment courses on each of these 
synthetic dose distributions. 
Results: Simulations of inter-fractional motion resulted in 7,10 and 18 
patients with an estimated average accumulated dose of at least 95% 
of the prescribed dose to 99% of the CTV (D99), for uniform margins 
around the prostate of 3mm, 4mm and 5mm, respectively. For the 
seminal vesicles and the pelvic lymph nodes, margin expansion of 
3mm, 5mm, 7mm, 9mm resulted in 1, 11, 15, 16 and 8, 18, 18, 18 
patients respectively with an expected average D99> 95% of the 
prescription. In Figure 1, the estimated average D99 including the10%-
90%-percentiles for each target are shown. 
 
 
Conclusions: We have developed a deformable registration based 
motion simulation model and successfully applied this on a 
comprehensive repeat CT data-set. For the patients included in this 
study, 90% had full target coverage with CTV-to-PTV expansions of 
5mm for the prostate, 11mm for the seminal vesicles and 5mm for the 
pelvic lymph nodes.  
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Purpose/Objective: Respiratory motion introduces complex spatio-
temporal variations in the dosimetry of radiotherapy and may 
contribute to uncertainties in radiotherapy planning. This novel in 
vitro study investigates the potential radiobiological implications 
occurring due to tumour motion in lung cancer radiotherapy. 
Materials and Methods: A bespoke phantom and motor-driven 
platform to replicate respiratory motion and study the consequences 
on tumour cell survival in vitro was constructed. Human non-small cell 
lung cancer cell lines (H460 and H1299) were irradiated in uniform (0-
8Gy) and modulated radiotherapy fields (4Gy) in the presence and 
absence of respiratory motion (14 and 21 respirations/minute). 
Clonogenic survival was calculated for irradiated and shielded regions. 
Direction of motion, replication of dosimetry by MLC manipulation and 
oscillating lead shielding were investigated to confirm differences. 
Differences were compared using the Mann-Whitney test. 
Results: No difference in survival was seen for cell lines uniformly 
irradiated with or without motion. With respiratory motion survival 
was significantly higher for out-of-field regions for H460 and H1299 
compared with static irradiation of 50% of the flask (p<0.0005). 
Significantly higher survival was found in the in-field region for the 
H460 cell line (p<0.03). Oscillating lead shielding also produced these 
significant differences. MLC and perpendicular motion had no 
significant difference compared to static irradiations. 
Conclusions: These data indicate that respiratory motion can impact 
on in- and out-of-field survival in the presence of non-uniform 
irradiation for lung cancer cell lines. This may have implications for 
the efficacy of radiotherapy particularly in areas where tumour is 
missed due to respiratory motion. 
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